Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CVM | AMGN | BMY | GILD | VRTX |
| Company | Cel-Sci Corp | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.6500 | 312.89 | 44.75 | 64.72 | 420.67 |
| High | 1.6600 | 314.89 | 44.88 | 66.20 | 421.20 |
| Low | 1.4600 | 310.87 | 44.30 | 64.67 | 417.50 |
| Last | 1.4698 | 313.79 | 44.81 | 66.12 | 420.32 |
| Change | -0.0402 | +0.93 | +0.07 | +1.54 | +1.33 |
| % Change | -2.66% | +0.30% | +0.16% | +2.38% | +0.32% |
| Volume | 254,925 | 1,326,122 | 3,379,900 | 4,837,794 | 465,109 |
| 20-Day Average Volume | 418,060 | 2,863,455 | 13,889,996 | 7,409,506 | 1,076,997 |
| Previous Close | 1.5100 | 312.86 | 44.74 | 64.58 | 418.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5090 | 281.79 | 46.00 | 65.99 | 401.83 |
| 20-Day Raw Stochastic | 12.61% | 85.76% | 22.03% | 35.39% | 85.16% |
| 20-Day Relative Strength | 42.63% | 68.37% | 35.60% | 38.93% | 61.00% |
| Weighted Alpha | -57.87 | +36.21 | -34.76 | -19.58 | +22.02 |
| Today's Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Previous Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Last Month's Opinion | 56% Sell | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.60% since 05/03/24 | +0.80% since 05/03/24 | +1.63% since 05/03/24 | +1.56% since 05/03/24 | +4.84% since 05/03/24 |
| Low | 1.3600 on 05/08/24 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 |
| High | 2.3900 on 05/08/24 | 314.89 on 05/10/24 | 44.88 on 05/10/24 | 66.20 on 05/10/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -10.78% since 04/10/24 | +17.77% since 04/10/24 | -11.11% since 04/10/24 | -3.42% since 04/10/24 | +5.77% since 04/10/24 |
| Low | 1.3600 on 05/08/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 2.3900 on 05/08/24 | 322.60 on 05/03/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -39.43% since 02/09/24 | +7.79% since 02/09/24 | -10.25% since 02/09/24 | -10.70% since 02/09/24 | -0.57% since 02/09/24 |
| Low | 1.3600 on 05/08/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 2.4978 on 03/07/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -36.33% since 11/10/23 | +17.39% since 11/10/23 | -11.67% since 11/10/23 | -13.34% since 11/10/23 | +12.54% since 11/10/23 |
| Low | 1.3600 on 05/08/24 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 3.2300 on 12/27/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,508 | 167,829,040 | 90,692,464 | 80,407,072 | 108,121,632 |
| Shares Outstanding, K | 53,979 | 536,435 | 2,027,100 | 1,245,077 | 258,053 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -32,190,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -6,710,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.23 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 02/14/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 41.59 | 16.11 | 27.81 |